HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$2.63
Day range
$2.62 - $2.68
Year range
$1.25 - $32.42
Market cap
76.79M USD
Avg Volume
1.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.16M | 28.66% |
Net income | -24.78M | -30.22% |
Net profit margin | — | — |
Earnings per share | -0.86 | -13.16% |
EBITDA | -26.14M | -28.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 104.20M | -30.58% |
Total assets | 111.69M | -28.29% |
Total liabilities | 17.30M | 25.07% |
Total equity | 94.40M | — |
Shares outstanding | 28.87M | — |
Price to book | 0.80 | — |
Return on assets | -59.87% | — |
Return on capital | -70.05% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -24.78M | -30.22% |
Cash from operations | -20.43M | -36.74% |
Cash from investing | 18.00M | 351.92% |
Cash from financing | 24.38M | -46.17% |
Net change in cash | 21.95M | -36.07% |
Free cash flow | -13.64M | -75.40% |
About
Founded
2018
Headquarters
Website
Employees
51
